FCER2 anticorps (AA 48-321)

N° du produit ABIN7158533

Détail du produit anti-FCER2 anticorps

Antigène: FCER2 (Fc Fragment of IgE, Low Affinity II, Receptor For (CD23) (FCER2))

Épitope: AA 48-321

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp FCER2 est non-conjugé

Application: Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Low affinity immunoglobulin epsilon Fc receptor protein (48-321AA)

Isotype: IgG

Information d'application

Indications d'application: Recommended dilution: IHC:1:500-1:1000, IF:1:50-1:200,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur FCER2

Antigène: FCER2 (Fc Fragment of IgE, Low Affinity II, Receptor For (CD23) (FCER2))

Autre désignation: FCER2 (FCER2 Produits)

Synonymes: anticorps BLAST-2, anticorps CD23, anticorps CD23A, anticorps CLEC4J, anticorps FCE2, anticorps IGEBF, anticorps Fcer2a, anticorps Fc fragment of IgE receptor II, anticorps FCER2, anticorps Fcer2

Sujet:

Background: Low-affinity receptor for immunoglobulin E (IgE) and CR2/CD21. Has essential roles in the regulation of IgE production and in the differentiation of B-cells (it is a B-cell-specific antigen).

Aliases: Blast 2 antibody, BLAST-2 antibody, Blast2 antibody, C type lectin domain family 4 member J antibody, C-type lectin domain family 4 antibody, C-type lectin domain family 4 member J antibody, C-type lectin domain family 4, member J antibody, CD 23 antibody, CD 23A antibody, CD23 antibody, CD23 antigen antibody, CD23A antibody, CLEC 4J antibody, CLEC4J antibody, Fc epsilon receptor II antibody, Fc epsilon RII antibody, Fc fragment of IgE antibody, Fc fragment of IgE low affinity II receptor for antibody, Fc fragment of IgE receptor II antibody, Fc fragment of IgE, low affinity II, receptor for (CD23) antibody, Fc of IgE antibody, Fc of IgE, low affinity II, receptor for (CD23) antibody, Fc receptor IgE low affinity II alpha polypeptide antibody, Fc receptor, IgE, low affinity II, alpha polypeptide, isoform CRA_a antibody, Fc-epsilon-RII antibody, FCE 2 antibody, FCE2 antibody, FCER 2 antibody, Fcer2 antibody, FCER2_HUMAN antibody, FCER2A antibody, FceRII antibody, IgE binding factor antibody, IgE receptor lymphocyte antibody, IgE-binding factor antibody, IGEBF antibody, Immunoglobulin E binding factor antibody, Immunoglobulin E receptor antibody, Immunoglobulin E receptor, low affinity II antibody, Immunoglobulin E-binding factor antibody, Immunoglobulin epsilon chain antibody, LEUKOCYTE ANTIGEN CD23 antibody, Low Affinity IgE Receptor antibody, Low affinity immunoglobulin epsilon Fc receptor antibody, Low affinity immunoglobulin epsilon Fc receptor membrane bound form antibody, Low affinity immunoglobulin epsilon Fc receptor soluble form antibody, Ly-42 antibody, Ly42 antibody, Lymphocyte antigen CD23 antibody, Lymphocyte IgE receptor antibody, MGC93219 antibody

UniProt: P06734

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process